sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Intravenous Immunoglobulin Market Scope And Analysis

  • Report Code : TIPRE00004079
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 210
Buy Now

Intravenous Immunoglobulin Market Scope and Key Players 2031

Buy Now

Intravenous Immunoglobulin Market Report Intravenous Immunoglobulin Market Size and Share Intravenous Immunoglobulin Market Scope and Analysis

Intravenous Immunoglobulin Market Report Scope

Report Attribute Details
Market size in 2021 US$ 11.21 Billion
Market Size by 2028 US$ 18.67 Billion
Global CAGR (2021 - 2028) 7.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • IgG
  • IgM
  • IgA
  • IgE
  • IgD
By Application
  • Hypogammaglobulinemia
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Immunodeficiency Diseases
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • Idiopathic Thrombocytopenic Purpura
  • Inflammatory Myopathies
  • Specific Antibody Deficiency
  • Guillain-Barre syndrome
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
By End User
  • Hospitals
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Takeda Pharmaceutical Company Limited
  • Grifols S A
  • Pfizer Inc
  • ADMA Biologics Inc
  • Bio Products Laboratory Ltd
  • Shanghai RAAS
  • Octapharma AG
  • Kedrion S p A
  • CSL Behring CSL Limited